OncoSynergy, Fighting Brain Cancer as the Family Business

OncoSynergy is a privately-held biotech company with a monoclonal antibody drug platform that is being developed for glioblastoma, the most aggressive form of brain cancer.

There is a great interview in Science Exchange this month with OncoSynergy's founder and CEO Shawn Carbonell, MD, PhD, and his wife, Anne-Marie Carbonell, MD, Vice President of Clinical Development.

In the interview, Shawn and Anne-Marie discuss their work on a drug that could be a game changer for patients with glioblastoma. They also talk about their involvement in the Race for Hope DC - the world's largest brain tumor community event, co-hosted by Accelerate Brain Cancer Cure and the National Brain Tumor Society.  OncoSynergy is the Social Media Sponsor of the 2014 Race for Hope DC.

Click HERE for the full article in Science Exchange.

Share |
October 15, 2014 12:44 PM
Principal Investigators, based in the state of Florida, are invited to apply. Proposal deadline: December 15, 2014. 
October 14, 2014 12:50 PM
ABC2 funds project between UC San Diego Health System and Regulus Therapeutics Inc.
September 30, 2014 12:43 PM
On October 31st and November 1st, 2014, brave participants fighting to end brain cancer will rappel 365 ft. and go Over the Edge for Brain Cancer (@OTE4BrainCancer).

Join us in our fight for a cure!

Twitter